Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank60
3Y CAGR+32.7%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+32.7%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$10.66M-46.5%
2024$19.93M+20.0%
2023$16.61M+264.2%
2022$4.56M-
2021$0.00-
2020$0.00-